BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maseda D, Ricciotti E. NSAID-Gut Microbiota Interactions. Front Pharmacol. 2020;11:1153. [PMID: 32848762 DOI: 10.3389/fphar.2020.01153] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Jardou M, Brossier C, Guiyedi K, Faucher Q, Lawson R. Pharmacological hypothesis: A recombinant probiotic for taming bacterial β-glucuronidase in drug-induced enteropathy. Pharmacol Res Perspect 2022;10:e00998. [PMID: 36082825 DOI: 10.1002/prp2.998] [Reference Citation Analysis]
2 Barone M, D'Amico F, Rampelli S, Brigidi P, Turroni S. Age-related diseases, therapies and gut microbiome: A new frontier for healthy aging. Mech Ageing Dev 2022;206:111711. [PMID: 35868543 DOI: 10.1016/j.mad.2022.111711] [Reference Citation Analysis]
3 Jackson A, Engen PA, Forsyth CB, Shaikh M, Naqib A, Wilber S, Frausto DM, Raeisi S, Green SJ, Bradaric BD, Persons AL, Voigt RM, Keshavarzian A. Intestinal Barrier Dysfunction in the Absence of Systemic Inflammation Fails to Exacerbate Motor Dysfunction and Brain Pathology in a Mouse Model of Parkinson's Disease. Front Neurol 2022;13:882628. [DOI: 10.3389/fneur.2022.882628] [Reference Citation Analysis]
4 Oncel S, Basson MD. Gut homeostasis, injury, and healing: New therapeutic targets. World J Gastroenterol 2022; 28(17): 1725-1750 [DOI: 10.3748/wjg.v28.i17.1725] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Donoso F, Cryan JF, Olavarría-Ramírez L, Nolan YM, Clarke G. Inflammation, Lifestyle Factors, and the Microbiome-Gut-Brain Axis: Relevance to Depression and Antidepressant Action. Clin Pharmacol Ther 2022. [PMID: 35278334 DOI: 10.1002/cpt.2581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Candeliere F, Raimondi S, Ranieri R, Musmeci E, Zambon A, Amaretti A, Rossi M. β-Glucuronidase Pattern Predicted From Gut Metagenomes Indicates Potentially Diversified Pharmacomicrobiomics. Front Microbiol 2022;13:826994. [DOI: 10.3389/fmicb.2022.826994] [Reference Citation Analysis]
7 Sagard J, Olofsson T, Mogard E, Marsal J, Andréasson K, Geijer M, Kristensen LE, Lindqvist E, Wallman JK. Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis. Arthritis Res Ther 2022;24. [DOI: 10.1186/s13075-022-02733-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Queiro-Silva R, García-Valle A, Alonso-Castro S, Alperi-López M. Do NSAIDs Take Us Away From Treatment Goals in Axial Spondyloarthritis: A Story About Dysbiosis or Just a Matter of Bias? Front Med (Lausanne) 2021;8:817884. [PMID: 35004794 DOI: 10.3389/fmed.2021.817884] [Reference Citation Analysis]
9 Azimirad M, Noori M, Raeisi H, Yadegar A, Shahrokh S, Asadzadeh Aghdaei H, Bentivegna E, Martelletti P, Petrosillo N, Zali MR. How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms? Front Med (Lausanne) 2021;8:775063. [PMID: 34966759 DOI: 10.3389/fmed.2021.775063] [Reference Citation Analysis]
10 Soto Ocaña J, Bayard NU, Zackular JP. Pain killers: the interplay between nonsteroidal anti-inflammatory drugs and Clostridioides difficile infection. Curr Opin Microbiol 2021;65:167-74. [PMID: 34894543 DOI: 10.1016/j.mib.2021.11.011] [Reference Citation Analysis]
11 Seth I, Bulloch G, Seth N, Siu A, Clayton S, Lower K, Roshan S, Nara N. Effect of Perioperative Vitamin C on the Incidence of Complex Regional Pain Syndrome: A Systematic Review and Meta-Analysis. J Foot Ankle Surg 2021:S1067-2516(21)00460-9. [PMID: 34961681 DOI: 10.1053/j.jfas.2021.11.008] [Reference Citation Analysis]
12 Fratter A, Biagi D, Giacomini I, Montopoli M, Cocetta V. Novel Adenosine Triphosphate-Based Nutraceutical Formulation to Prevent Non-Steroidal Anti-Inflammatory Drug Enteric Cell Toxicity: Preliminary In Vitro Evidence. J Med Food 2021. [PMID: 34491844 DOI: 10.1089/jmf.2021.0019] [Reference Citation Analysis]
13 Seely KD, Kotelko CA, Douglas H, Bealer B, Brooks AE. The Human Gut Microbiota: A Key Mediator of Osteoporosis and Osteogenesis. Int J Mol Sci 2021;22:9452. [PMID: 34502371 DOI: 10.3390/ijms22179452] [Reference Citation Analysis]
14 Domper Arnal MJ, Hijos-Mallada G, Lanas A. Gastrointestinal and cardiovascular adverse events associated with NSAIDs. Expert Opin Drug Saf 2021;:1-12. [PMID: 34376069 DOI: 10.1080/14740338.2021.1965988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wang X, Tang Q, Hou H, Zhang W, Li M, Chen D, Gu Y, Wang B, Hou J, Liu Y, Cao H. Gut Microbiota in NSAID Enteropathy: New Insights From Inside. Front Cell Infect Microbiol 2021;11:679396. [PMID: 34295835 DOI: 10.3389/fcimb.2021.679396] [Reference Citation Analysis]
16 McEvoy L, Carr DF, Pirmohamed M. Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity. Front Pharmacol 2021;12:684162. [PMID: 34234675 DOI: 10.3389/fphar.2021.684162] [Reference Citation Analysis]
17 Hijos-Mallada G, Sostres C, Gomollón F. NSAIDs, gastrointestinal toxicity and inflammatory bowel disease. Gastroenterol Hepatol 2021:S0210-5705(21)00201-6. [PMID: 34157367 DOI: 10.1016/j.gastrohep.2021.06.003] [Reference Citation Analysis]
18 Biondi A, Basile F, Vacante M. Familial adenomatous polyposis and changes in the gut microbiota: New insights into colorectal cancer carcinogenesis. World J Gastrointest Oncol 2021; 13(6): 495-508 [PMID: 34163569 DOI: 10.4251/wjgo.v13.i6.495] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Clayton P, Hill M, Bogoda N, Subah S, Venkatesh R. Palmitoylethanolamide: A Natural Compound for Health Management. Int J Mol Sci 2021;22:5305. [PMID: 34069940 DOI: 10.3390/ijms22105305] [Reference Citation Analysis]
20 Hecquet S, Totoson P, Martin H, Prati C, Wendling D, Demougeot C, Verhoeven F. Intestinal permeability in spondyloarthritis and rheumatoid arthritis: A systematic review of the literature. Semin Arthritis Rheum 2021;51:712-8. [PMID: 34139524 DOI: 10.1016/j.semarthrit.2021.04.015] [Reference Citation Analysis]
21 Głowacka U, Magierowska K, Wójcik D, Hankus J, Szetela M, Cieszkowski J, Korbut E, Danielak A, Surmiak M, Chmura A, Wallace JL, Magierowski M. Microbiome Profile and Molecular Pathways Alterations in Gastrointestinal Tract by Hydrogen Sulfide-Releasing Nonsteroidal Anti-Inflammatory Drug (ATB-352): Insight into Possible Safer Polypharmacy. Antioxid Redox Signal 2021. [PMID: 33678013 DOI: 10.1089/ars.2020.8240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Franza L, Carusi V, Nucera E, Pandolfi F. Luteolin, inflammation and cancer: Special emphasis on gut microbiota. Biofactors 2021;47:181-9. [PMID: 33507594 DOI: 10.1002/biof.1710] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
23 Oakes B, Bolia IK, Weber AE, Petrigliano FA. Vitamin C in orthopedic practices: Current concepts, novel ideas, and future perspectives. J Orthop Res 2021;39:698-706. [PMID: 33300201 DOI: 10.1002/jor.24947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Bjarnason I, Rainsford KD. NSAID-enteropathy and intestinal microbes. Inflammopharmacology 2021;29:1-4. [PMID: 33058017 DOI: 10.1007/s10787-020-00766-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]